Biological fluid shunting device and method

By designing a glaucoma shunt device including a main pipe, sub-tube and shunt body, the permanent attachment is achieved using adhesive and friction combination, the problems of bulkiness and inflexibility of existing devices are solved, and stable biological fluid drainage and water atrial fluid Reabsorption reduces the risk of inflammation.

CN119012987APending Publication Date: 2024-11-22WL GORE & ASSOC INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380031991.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-03-29
Filing Date
2023-03-29
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

Existing shunt devices for the treatment of glaucoma are bulky and inflexible, lacking the ability to firmly anchor the surrounding tissue, leading to relative movement between the device and tissue, causing chronic inflammation and scar formation, and affecting the reabsorption of water aquaculture.

Method used

A glaucoma shunt device including a main pipe, a sub-tube and a shunt body is designed. Through the integration of the main pipe and a sub-tube with the shunt body, the permanent attachment is achieved using adhesive and friction fit to ensure fluid drainage and through The length of the device can be trimmed to maintain a constant flow resistance and flow rate.

Benefits of technology

More flexible and stable biological fluid drainage is achieved, which reduces the relative movement of the device and tissue, reduces the risk of inflammation, improves the reabsorption efficiency of aqueous humor, and stabilizes the intraocular pressure.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119012987A_ABST
    Figure CN119012987A_ABST
Patent Text Reader

Abstract

A glaucoma shunt device (100) is presented for draining biological fluid from an eye. The glaucoma shunt device comprises a main tube (102), a secondary tube (104) and a shunt body (106). The main tube has a main proximal end (108), a main distal end (110), and a main tube (112) extending therebetween. The secondary tube has a secondary proximal end (114), a secondary distal end (116), and a secondary conduit (118) extending therebetween. The secondary tube is at least partially inserted through the primary tube via the primary distal end. The secondary tube defines a flow resistance of the primary tube and the secondary tube. The diverter body has a reservoir therein and is integral with the primary conduit near the primary distal end such that the primary conduit and the secondary conduit are fluidly coupled with the reservoir.
Need to check novelty before this filing date? Find Prior Art

Description

CROSS-REFERENCE TO RELATED APPLICATIONS

[0001] This application claims the benefit of U.S. Provisional Patent Application No. 63 / 324,777, filed on March 29, 2022, which is incorporated herein by reference in its entirety for all purposes. Technical Field

[0002] The present disclosure generally relates to devices and methods for draining biological fluids and transferring fluids to be reabsorbed elsewhere in the body. More specifically, the present disclosure relates to devices and methods for draining aqueous humor from the anterior chamber of a patient's eye so that the aqueous humor can be reabsorbed by the body. Background Art

[0003] Various medical interventions involve draining excess biological fluid from one part of the body and redirecting it to another location of the body where the fluid can be reabsorbed. In some cases, this drainage is achieved through minimally invasive surgery, such as endoscopic third ventriculostomy (ETV) and choroid plexus cauterization (CPC). In other cases, this drainage is performed postoperatively via an implantable medical device such as a shunt. Different forms of shunts have been used to treat a variety of diseases, such as hydrocephalus and glaucoma, which have proven useful in various medical procedures.

[0004] If left untreated, excess biofluid can lead to an unhealthy buildup of pressure. For example, glaucoma is a progressive eye disease characterized by elevated intraocular pressure. Aqueous humor is a fluid that fills the anterior chamber (AC) of the eye and contributes to intraocular pressure or fluid pressure within the eye. This rise in intraocular pressure is usually caused by insufficient amounts of aqueous humor being absorbed by the body. In some cases, the aqueous humor is not absorbed quickly enough or is not even absorbed at all, while in other cases, the aqueous humor is additionally or alternatively produced too quickly. Elevated intraocular pressure is associated with a gradual and sometimes permanent loss of vision in the diseased eye.

[0005] Various attempts to treat glaucoma have been made, including devices that are relatively bulky, inflexible, non-compliant, and lack a firm anchoring capability to the surrounding tissue resulting in relative motion between the device and the tissue. This motion may result in continued irritation of the surrounding tissue, causing irritation at the implant site. Irritation, in turn, may result in increased chronic inflammatory tissue response, excessive scarring at the device site, and increased risk of device corrosion through conjunctivitis and endophthalmitis. Scar tissue effectively prevents reabsorption of aqueous humor without corrosion and interference with device function. Summary of the invention

[0006] Disclosed herein are shunt devices for draining biological fluid from an eye to tissue surrounding the eye, as well as methods of forming shunt devices that are at least partially implantable within tissue of the eye and methods of using the shunt devices to treat glaucoma.

[0007] According to one example ("Example 1"), a glaucoma shunt device for draining biological fluid from an eye is provided, wherein the glaucoma shunt device includes: a main tube, a secondary tube, and a shunt body. The main tube has a main proximal end, a main distal end, and a main conduit extending therebetween. The secondary tube has a secondary proximal end, a secondary distal end, and a secondary conduit extending therebetween. The secondary tube is at least partially inserted through the main conduit via the main distal end. The secondary tube defines the flow resistance of the main tube and the secondary tube. The shunt body has a storage portion therein and is integrated with the main tube near the main distal end so that the main conduit and the secondary conduit are fluidically connected to the storage portion.

[0008] According to another example (“Example 2”) further than Example 1, the secondary pipe is permanently attached to the primary pipe.

[0009] According to another example ("Example 3") that is further developed relative to Example 2, the permanent attachment is facilitated by an adhesive disposed between the outer surface of the secondary pipe and the inner surface of the primary pipe.

[0010] According to another example (“Example 4”) that is further developed relative to Example 2, the permanent attachment is facilitated by a friction fit between the outer surface of the secondary pipe and the inner surface of the primary pipe.

[0011] According to another example ("Example 5") that is further relative to any of the aforementioned examples, the secondary distal end extends distally beyond the primary distal end and into the reservoir.

[0012] According to another example (“Example 6”) further relative to any one of Examples 1-4, the diverter body includes a neck portion, and the main pipe is attached to the diverter body at the neck portion.

[0013] According to another example (“Example 7”) further relative to Example 6, both the primary distal end and the secondary distal end are positioned at the neck portion of the shunt body.

[0014] According to another example (“Example 8”) further relative to Example 6, the primary distal end is positioned at a neck portion of the shunt body, and the secondary distal end is positioned proximally relative to the neck portion.

[0015] According to another example ("Example 9") further relative to Example 6, the main distal end extends distally beyond the neck portion of the shunt body and into the reservoir, and the secondary distal end is positioned at the neck portion.

[0016] According to another example ("Example 10") further relative to Example 6, the primary distal end extends distally beyond the neck portion of the shunt body and into the reservoir, and the secondary distal end is positioned proximally relative to the neck portion.

[0017] According to another example (“Example 11”) further than Example 6, the sub-pipe is completely disposed at or within the neck portion.

[0018] According to another example ("Example 12") further relative to any of the preceding examples, the main tube is permanently attached to the shunt body at or near the main distal end.

[0019] According to another example ("Example 13") further than any of the foregoing examples, the primary proximal end proximally extends beyond the secondary proximal end by a predetermined length to define a trimmable portion of the primary tube. The total length of the primary tube defines a first state of the combined primary and secondary tubes that is not trimmed, and further defines a second state of the combined primary and secondary tubes that is trimmed to a shorter length of the trimmable portion. Both the first state and the second state have the same flow resistance.

[0020] According to another example (“Example 14”) further than Example 13, the secondary pipe maintains a constant flow rate therethrough before and after the primary pipe is shortened.

[0021] According to another example ("Example 15") further relative to any of the aforementioned examples, the secondary conduit has a smaller diameter than the primary conduit, so that the diameter of the secondary conduit is the main determinant of the flow resistance of the fluid entering the reservoir.

[0022] According to another example ("Example 16") further to any of the preceding examples, the length of the secondary conduit is a secondary determinant of the flow resistance of the fluid entering the reservoir.

[0023] According to one example ("Example 17"), a glaucoma shunt device for draining a biological fluid from an eye includes a tube and a shunt body. The tube includes a main portion having a main conduit and a secondary portion having a secondary conduit. The main conduit has a main diameter greater than the secondary diameter of the secondary conduit. The main portion is positioned proximally relative to the secondary portion. The secondary conduit has a flow resistance. The shunt body has a reservoir therein and is integrated with the tube at the secondary portion so that the main conduit and the secondary conduit are fluidically coupled to the reservoir.

[0024] According to another example ("Example 18") further than Example 17, a section of the secondary portion extends distally into the reservoir.

[0025] According to another example (“Example 19”) further relative to Example 18, the diverter body includes a neck portion, and the tube is attached to the diverter body at the neck portion.

[0026] According to another example (“Example 20”) further relative to Example 19, the distal end of the pipe is positioned at a neck portion of the diverter body.

[0027] According to another example ("Example 21") further than Example 19, the secondary portion of the tube is completely disposed at or within the neck portion.

[0028] According to another example ("Example 22") further relative to Example 18, the tube includes a proximal main portion positioned proximally relative to the secondary portion and partially defining the main conduit, a distal main portion positioned distally relative to the secondary portion and partially defining the main conduit, a first transition portion positioned between the proximal main portion and the secondary portion, and a second transition portion positioned between the distal main portion and the secondary portion.

[0029] According to another example ("Example 23") further relative to Example 22, the distal end of the tube is positioned at the neck portion of the diverter body, and both the first transition portion and the second transition portion are positioned proximally relative to the neck portion.

[0030] According to another example ("Example 24") further relative to Example 22, the distal end of the tube extends distally beyond the neck portion of the diverter body and into the storage portion, the second transition portion is positioned at the neck portion, and the first transition portion is positioned proximally relative to the neck portion.

[0031] According to another example ("Example 25") further relative to Example 22, the distal end of the tube extends distally beyond the neck portion of the shunt body, and both the first transition portion and the second transition portion are positioned proximally relative to the neck portion.

[0032] According to another example ("Example 26") that is further than any one of Examples 17-25, the main portion extends proximally relative to the secondary portion by a predetermined length, so that the total length of the tube can be shortened by cutting the main portion of the tube along a section extending proximally beyond the secondary portion without affecting the flow resistance of the secondary conduit.

[0033] According to another example ("Example 27") further than Example 26, the secondary conduit maintains a constant flow rate therethrough before and after the main portion of the tube is shortened.

[0034] According to another example ("Example 28") further relative to any one of Examples 17-27, the secondary conduit has a smaller diameter than the primary conduit, so that the diameter of the secondary conduit is the main determinant of the flow resistance of the fluid entering the reservoir.

[0035] According to another example ("Example 29") further relative to any of Examples 17-28, the length of the secondary conduit is a secondary determining factor of the flow resistance of the fluid entering the reservoir.

[0036] According to one example ("Example 30"), a method of forming a drainage device capable of being at least partially implanted in tissue of an eye is disclosed. The method includes: forming a shunt body having a reservoir defined therein, the reservoir being configured to receive and accumulate biological fluid; preparing a main tube having a main proximal end, a main distal end, and a main conduit extending therebetween, and a secondary tube having a secondary proximal end, a secondary distal end, and a secondary conduit extending therebetween and having a flow resistance; inserting the secondary tube through the main conduit at least partially via the main distal end; and integrating the shunt body with the main conduit near the main distal end, so that the main conduit, the secondary conduit and the reservoir are fluidically coupled, and the main proximal end of the main tube can be delivered into the eye to facilitate drainage of biological fluid into the main conduit.

[0037] According to another example (“Example 31”) further than Example 30, the method includes permanently attaching the secondary pipe to the primary pipe.

[0038] According to another example ("Example 32") further relative to Example 31, the method includes providing an adhesive between an outer surface of the secondary tube and an inner surface of the primary tube before at least partially inserting the secondary tube through the primary distal end.

[0039] According to another example ("Example 33") further relative to any of Examples 30-32, the method includes positioning the secondary distal end to extend distally beyond the primary distal end and into the reservoir.

[0040] According to another example ("Example 34") further relative to any of Examples 30-33, the method includes permanently attaching the main tube to the diverter body at or near the main distal end.

[0041] According to another example ("Example 35") that is further than any one of Examples 30-34, the method includes positioning the main proximal end to extend proximally beyond the secondary proximal end by a predetermined length, so that the total length of the main tube can be shortened by cutting the main tube along a section extending proximally beyond the secondary tube without affecting the flow resistance of the secondary conduit.

[0042] According to another example (“Example 36”) further relative to Example 35, the method includes maintaining a constant flow rate through the secondary conduit before and after shortening the primary conduit.

[0043] According to another example ("Example 37") further relative to any one of Examples 30-36, the method includes forming a secondary pipe so that the secondary pipe has a diameter smaller than the main pipe, and the diameter of the secondary pipe is the main determinant of the flow resistance of the fluid entering the storage portion.

[0044] According to another example ("Example 38") further to any of Examples 30-37, the length of the secondary conduit is a secondary determining factor of the flow resistance of the fluid entering the reservoir.

[0045] According to one example ("Example 39"), a method of forming a drainage device capable of being at least partially implanted in tissue of an eye is disclosed. The method includes: forming a shunt body having a reservoir defined therein, the reservoir being configured to receive and accumulate biological fluid; preparing a tube having a main portion with a main conduit and a secondary portion with a secondary conduit, the main conduit having a main diameter greater than the secondary diameter of the secondary conduit, the main portion being positioned proximally relative to the secondary portion, and the secondary conduit having a flow resistance; and integrating the shunt body with the tube at the secondary portion so that the main conduit and the secondary conduit are fluidically coupled to the reservoir, and the main portion of the main tube can be delivered into the eye to facilitate drainage of biological fluid into the main conduit.

[0046] According to another example ("Example 40") further than Example 39, the method includes extending the secondary portion of the tube at least partially distally into the reservoir.

[0047] According to another example ("Example 41") further than Example 39 or 40, the method includes forming a tube so that the main portion extends proximally by a predetermined length relative to the secondary portion, and the overall length of the tube can be shortened by cutting the main portion of the tube along a section extending proximally beyond the secondary portion without affecting the flow resistance of the secondary conduit.

[0048] According to another example ("Example 42") further relative to Example 41, the method includes maintaining a constant flow rate through the secondary conduit before and after shortening the main portion of the tube through the secondary portion.

[0049] According to another example ("Example 43") further relative to any of Examples 39-42, the method includes forming the tube so that the secondary conduit has a diameter smaller than the main conduit, and the diameter of the secondary conduit is the primary determinant of fluid flow resistance entering the storage portion.

[0050] According to another example ("Example 44") further relative to any of Examples 39-43, the length of the secondary conduit is a secondary determining factor of the flow resistance of the fluid entering the reservoir.

[0051] According to an example ("Example 45"), a method of draining a biological fluid from a human eye via a tube extending from a glaucoma shunt body is disclosed, the tube having a tube proximal end disposed in the human eye to receive the biological fluid, and a tube distal end engaged with the glaucoma shunt body to fluidly connect the tube proximal end to a reservoir disposed in the glaucoma shunt body. The method includes: directing the biological fluid through the tube at a first flow resistance at the tube proximal end; directing the biological fluid through the tube between the tube proximal end and the tube distal end at a second flow resistance greater than the first flow resistance; and directing the biological fluid from the tube distal end into the reservoir.

[0052] According to one example ("Example 46"), a method of reducing fluid pressure in a human eye to reduce the risk of hypotony is disclosed. The method includes: directing fluid in the eye into a proximal end of a tube having a first flow resistance; then directing the fluid into a portion of the tube having a second flow resistance greater than the first flow resistance; and then directing the fluid from the distal end of the tube and into a reservoir.

[0053] According to another example ("Example 47") further relative to Example 45 or 46, the method includes trimming the proximal end of the tube to reduce the length of the tube while maintaining the second flow resistance.

[0054] According to another example (“Example 48”) further relative to any of Examples 45-47, the first flow resistance and the second flow resistance define a combined tube flow resistance, and the method includes trimming the proximal end of the tube to reduce the tube length while maintaining the combined tube flow resistance.

[0055] According to another example ("Example 49") further relative to any one of Examples 45-48, the distal end of the tube is configured to extend into the storage portion.

[0056] According to another example ("Example 50") that is further relative to any one of Examples 45-49, the method includes immediately after directing the fluid into a portion of the tube having a second flow resistance, subsequently directing the fluid into another portion of the tube having a third flow resistance that is less than the second flow resistance.

[0057] According to one example ("Example 51"), a method of reducing fluid pressure in a human eye to reduce the risk of hypotony is disclosed. The method includes directing fluid in the eye through a proximal end of a tube and into a reservoir disposed at a different position relative to the proximal end of the tube. Between the proximal end of the tube and a distal end of the tube disposed adjacent to the reservoir, a flow resistance of the tube is increased to limit the flow through the tube to a level sufficient to reduce the risk of hypotony. The increase in flow resistance occurs between the proximal end of the tube and the distal end of the tube.

[0058] According to another example ("Example 52") further than Example 51, the method includes trimming the proximal end of the tube to reduce the length of the tube while maintaining flow resistance.

[0059] According to another example ("Example 53") further than Example 51 or 52, the distal end of the tube is configured to extend into the storage portion.

[0060] According to another example (“Example 54”) that is further relative to any one of Examples 51-53, the flow resistance decreases between the point where the flow resistance increases and the distal end of the tube.

[0061] The foregoing examples are merely examples and should not be construed as limiting or otherwise narrowing the scope of any inventive concept otherwise provided in this disclosure. Although a number of examples are disclosed, other embodiments will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative examples. Therefore, the drawings and detailed description should be considered illustrative in nature and not restrictive in nature. BRIEF DESCRIPTION OF THE DRAWINGS

[0062] The accompanying drawings are included to provide a further understanding of the disclosure and are incorporated in and constitute a part of this specification, illustrate embodiments and together with the description serve to explain the principles of the disclosure.

[0063] Figure 1A is a cross-sectional view of a glaucoma shunt device having a tube according to an embodiment disclosed herein;

[0064] Figure 1B As seen from one end (proximal end) of the tube Figure 1A A side view of a glaucoma shunt device is shown with a tube extending from the glaucoma shunt device;

[0065] Figure 1C is a cross-sectional side view of an eye having a shunt device implanted therein consistent with aspects of the present disclosure;

[0066] Figure 1D is a cross-sectional view of a portion of a tube extending from a glaucoma shunt device according to embodiments disclosed herein;

[0067] Figure 1E is a cross-sectional view of a portion of a tube extending from a glaucoma shunt device according to another embodiment disclosed herein;

[0068] Figure 2-7 are cross-sectional views of various glaucoma shunt devices having tubes according to various embodiments disclosed herein;

[0069] Fig. 8A is a cross-sectional view of a glaucoma shunt device having a tube according to an embodiment disclosed herein;

[0070] Figure 8B As seen from one end (proximal end) of the tube Fig. 8AA side view of a glaucoma shunt device is shown with a tube extending from the glaucoma shunt device;

[0071] Figure 9-13 are cross-sectional views of various glaucoma shunt devices, each device having a tube, according to various embodiments disclosed herein; and

[0072] Fig.14A and Fig. 14B is a cross-sectional view of a portion of a tube showing a transition portion thereof according to various embodiments disclosed herein.

[0073] It should be understood that the drawings and photographs are not necessarily reproduced to scale. In some cases, details that are not necessary for understanding the present disclosure or details that make other details difficult to perceive may be omitted. Of course, it should be understood that the present disclosure is not necessarily limited to the specific examples or embodiments described or depicted herein. DETAILED DESCRIPTION Definitions and terminology

[0074] This disclosure is not intended to be read in a limiting manner.For example, the terms used in this application should be read broadly in the context of the meaning that one skilled in the art would attribute to such terms.

[0075] Regarding imprecise terms, the terms "about" and "approximately" are used interchangeably to refer to measurements including the measured value and also any measurements that are reasonably (fairly) close to the measured value. As understood and easily determined by a person of ordinary skill in the relevant art, a measurement that is reasonably (fairly) close to the measured value deviates from the measured value by a reasonably small amount. Such deviations may be attributed to, for example, measurement errors, differences in calibration of the measured values ​​and / or manufacturing equipment, human errors in reading and / or setting the measured values, fine-tuning to optimize performance and / or structural parameters in view of differences in the measured values ​​associated with other components, specific implementation scenarios, imprecise adjustments and / or manipulations of objects by humans or machines, and / or the like. In the case where it is determined that a person of ordinary skill in the relevant art will not easily determine a value for such a reasonably small difference, the terms "about" and "approximately" may be understood as the value plus or minus 10%.

[0076] The phrases "at least one", "one or more", and "and / or" are open-ended expressions that can be either conjunctive (combined) or disjunctive when the expressions are effective. For example, each of the expressions "at least one of A, B, and C", "at least one of A, B, or C", "one or more of A, B, and C", "one or more of A, B, or C", and "A, B, and / or C" refers to A alone; B alone; C alone; A and B together; A and C together; B and C together; or A, B, and C together. When each of A, B, and C in the above expressions refers to an element, such as X, Y, and Z, or a class of elements, such as X1-X n 、Y1-Y m and Z1-Z o When the phrase is used, it means a single element selected from X, Y and Z, a combination of elements selected from the same class (e.g., X1 and X2), and a combination of elements selected from two or more classes (e.g., Y1 and Z o ).

[0077] It should be understood that each maximum numerical limitation given throughout this disclosure is considered to include each lower numerical limitation as an alternative, just as these lower numerical limitations are clearly written in this article. Each minimum numerical limitation given throughout this disclosure is considered to include each higher numerical limitation as an alternative, just as these higher numerical limitations are clearly written in this article. Each numerical range given throughout this disclosure is considered to include each narrower numerical range that falls within such a wider numerical range, just as these narrower numerical ranges are clearly written in this article.

[0078] Before any embodiment of the present disclosure is described in detail, it should be understood that the present disclosure is not limited to the application thereof to the details of the construction and the arrangement of parts described in the following description or shown in the accompanying drawings. The present disclosure can have other embodiments and can be practiced or implemented in various ways. Moreover, it should be understood that the words and terms used herein are for descriptive purposes and should not be considered as limiting. "Containing", "including" or "having" and variations thereof used herein are intended to include the items listed thereafter and their equivalents and additional items. Description of various embodiments

[0079] Various embodiments are directed to shunts that may be implanted in the eye to divert these fluids away from the AC of the eye and accommodate a means of avoiding or preventing hypotony. However, such shunts merely define a lumen to redirect fluid from the AC to a different location at a lower pressure than the AC and therefore do not include any components to redirect the flow of fluid after it leaves the AC. In other words, there is no component in the shunt that contains the fluid once it reaches its destination, which is a location at a lower pressure than the AC.

[0080] Furthermore, such shunts provide initial flow restriction only during the period of shunt implantation. Shunts use a dissolvable plug segment to provide initial outflow resistance to avoid intraocular hypotony and hypotony in the early postoperative period, and then increase flow over time by reducing outflow resistance to compensate for the increased biologic outflow resistance after surgery is complete. Therefore, shunts do not provide a long-term means of avoiding or preventing intraocular hypotony.

[0081] Those skilled in the art will readily appreciate that various aspects of the present disclosure may be implemented by any number of methods and devices configured to perform the desired functions. It should also be noted that the drawings referenced herein are not necessarily drawn to scale, but may be exaggerated to illustrate various aspects of the present disclosure, and in this regard, the drawings should not be construed as limiting.

[0082] Various features of the devices and methods disclosed herein can be seen in the figures. Various aspects of the present disclosure relate to drainage devices and methods for biological fluids. For example, the present disclosure relates to a device for draining a biological fluid from an eye 10 ( Figure 1C ) to drain aqueous humor from the anterior chamber (AC) so that it can be reabsorbed elsewhere by the body.

[0083] Figure 1C An eye 10 is shown with a subconjunctival space 11 between the conjunctiva 13 and the sclera 15 of the eye 10. A drainage system having a drainage or shunt device 100 according to the principles of the present disclosure is implanted within the eye 10. In one aspect of the present disclosure, a mechanism is provided for reabsorbing aqueous humor that has been drained from the AC of the eye 10 to reduce or otherwise stabilize intraocular pressure. However, those skilled in the art will appreciate that aspects of the present disclosure are useful in other applications where drainage of biological fluids to be redirected in vivo is desired.

[0084] Figure 1A and Figure 2-7Different features of a shunt device or glaucoma drainage device 100 for treating glaucoma according to some embodiments are shown. The shunt device 100 is an implantable device that can be used to drain biological fluid from the eye to tissue surrounding the eye when at least partially implanted in the tissue of the eye. The shunt device 100 has a main tube 102 having a first length L1 (also referred to as the "total length" or "untrimmed length" if it refers to the length before the tube is trimmed), a secondary tube 104 having a second length L2, and a shunt body 106. The main tube has a main proximal end 108, a main distal end 110, and a main conduit 112 extending between the two ends. The secondary tube 104 has a secondary proximal end 114, a secondary distal end 116, and a secondary conduit 118 extending between the two ends. The shunt body 106 has a reservoir 120 therein. The flow diverter body 106 is integral with the primary conduit 102 near the primary distal end 110 such that the primary conduit 112 and the secondary conduit 118 are fluidly coupled to the reservoir 120 .

[0085] It will be understood that the terms "proximal" and "distal" are used hereinafter relative to the perspective of a physician or surgeon performing a surgical procedure to implant a shunt device into the ocular tissue of a patient. In various examples, the shunt device is implanted by inserting the end with the shunt body into an incision formed in the ocular tissue and then inserting the opposite end of the tube into another part of the eye, such as the interior of the AC, to drain fluid therefrom. Thus, the shunt body can be referred to as being further (laterally) from the actual worker relative to the end of the tube protruding from the shunt body.

[0086] In some embodiments, Figure 1D and 1E As shown, the secondary tube 104 is at least partially inserted through the primary conduit 112 via the primary distal end 110. When viewed from the primary proximal end 108, as shown in FIG. Figure 1B As shown, the secondary conduit 118 defined by the secondary conduit 104 is found to have a narrower diameter, or D2, than the primary conduit 112 defined by the primary conduit 102, which has an inner diameter D1. Thus, the secondary conduit 104 defines the flow resistance of the primary and secondary conduits.

[0087] like Figure 1AAs shown by the dotted arrows drawn in , once implanted in the eye tissue, fluid from the environment is allowed to flow from the main proximal end 108 into the main conduit 112, through the main conduit 112, then through the secondary conduit 118, and finally leave the tube via the secondary distal end 116. Since the conduit diameter of the outlet (the secondary distal end 116 with a diameter of D2) is smaller than the inlet (the main proximal end 108 with a diameter of D1), the resistance to the fluid flowing through the tube and entering the storage portion 120 is mainly determined by the smaller diameter D2 of the secondary conduit 118. Therefore, the diameter of the secondary conduit is the main determinant of the flow resistance of the fluid entering the storage portion. In some examples, the length (L2) of the secondary conduit may be a secondary determinant of the flow resistance of the fluid entering the storage portion. The determined flow resistance remains unchanged during and after the implantation of the shunt device 100, so that the flow resistance remains substantially constant throughout the use of the shunt device.

[0088] A primary determinant is defined as having a greater influence on the value of the flow resistance than a secondary determinant. Such a determinant is defined according to the Hagen-Poiseuille equation: Where Δp is the pressure difference between the two ends of the pipe as the fluid passes through it, μ is the dynamic viscosity, L is the length of the pipe, Q is the volume flow rate, and R is the radius of the pipe. The flow resistance is defined as Δp / Q. Therefore, from Equation 1, it can be seen that a change in the radius (and diameter) of the end portion of the pipe from which the fluid exits has a greater effect (fourth power) on the flow rate (Q) than a change in the length of the pipe (first power).

[0089] In some examples, secondary pipe 104 is permanently attached to primary pipe 102. Figure 1D and 1E As shown, the permanent attachment between the secondary pipe 104 and the primary pipe 102 includes an attachment between an outer surface 130 of the secondary pipe 104 and an inner surface 132 of the primary pipe 112 or the primary pipe 102. Figure 1D In FIG. 1 , the friction between the outer surface 130 and the inner surface 132 alone is sufficient to permanently attach the two tubes together (via a friction fit). Figure 1E In the embodiment, another component, such as any suitable adhesive 134, such as an adhesive polymer material, may be placed between the outer surface 130 and the inner surface 132 to facilitate permanent attachment. Once the tubes 102 and 104 are permanently attached, they are prevented from sliding relative to each other.

[0090] In some embodiments, the main tube 102 has a portion that does not overlap with the secondary tube 104, which is referred to as a trimmable portion 122. The trimmable portion 122 extends proximally relative to the secondary proximal end 114 and is so named because the length of the main tube 102 can be adjusted by trimming or cutting the main tube at the trimmable portion without affecting the flow resistance of the tube. In various examples, no matter where the main tube 102 is cut or trimmed along the trimmable portion 122 to shorten the length L1 of the main tube, the resulting tube (with a shorter length L1) will have the same flow resistance through it as before cutting or trimming. In some examples, the secondary conduit maintains a constant flow rate through it before and after the main tube is shortened.

[0091] As shown, in addition to the reservoir 120, the shunt body 106 also includes a neck portion 124, which is the portion of the shunt body 106 that contacts the main tube 102. The neck portion 124 can be a portion of the shunt body 106 that extends proximally for a predetermined distance. In some examples, the neck portion 124 can be an elongated rectangular continuous extension from the shunt body 106. The neck portion 124 can have a sufficient width and length to provide structural support for the main tube 102 that is at least partially attached or attached at the neck portion 124. The main tube 102 can be attached to the neck portion 124 in one of different configurations, as described herein with reference to Figure 1A and 2 -7 explained.

[0092] exist Figure 1A , the main tube 102 is attached to the neck portion 124 so that the main distal end 110 of the main tube is located at the neck portion. In other words, the main distal end of the main tube is located between the proximal end 126 and the distal end 128 of the neck portion. The neck portion has a length (Ln) defined by the proximal end 126 and the distal end 128, and the main distal end 110 is positioned within this length. The secondary distal end 116 extends distally relative to the main distal end 110 so that the secondary distal end extends into the reservoir 120 and is positioned in the reservoir to facilitate fluid flow into the reservoir, as shown by the dashed arrow extending from the secondary distal end. The secondary proximal end 114 of the secondary tube 104 is positioned proximally relative to the neck portion 124.

[0093] exist Figure 2 124, the main tube 102 is attached to the neck portion 124 so that the main distal end 110 of the main tube 102 extends distally beyond the neck portion 124 so that both the main distal end 110 of the main tube 102 and the secondary distal end 116 of the secondary tube 104 are positioned within the reservoir 120. The secondary proximal end 114 of the secondary tube 104 is positioned proximally relative to the neck portion 124.

[0094] exist Figure 3In the embodiment of the present invention, the main tube 102 is attached to the neck portion 124 so that both the main distal end 110 of the main tube 102 and the secondary distal end 116 of the secondary tube 104 are positioned at or within the neck portion 124. In other words, the positions of the main distal end 110 and the secondary distal end 116 may be at or within the length Ln of the neck portion 124. The secondary proximal end 114 of the secondary tube 104 is positioned proximally relative to the neck portion 124, and the secondary distal end 116 is positioned proximally relative to the main distal end 110 of the main tube. Therefore, the main conduit 112 extends both distally and proximally relative to the secondary conduit 118.

[0095] exist Figure 4 , the main tube 102 is attached to the neck portion 124 so that the main distal end 110 of the main tube 102 is positioned at or within the neck portion 124, and the secondary distal end 116 of the secondary tube 104 is positioned proximally relative to the neck portion 124. Both the secondary proximal end 114 and the secondary distal end 116 of the secondary tube 104 are positioned proximally relative to the neck portion 124, and the secondary distal end 116 is positioned proximally relative to the main distal end 110 of the main tube. Therefore, the main tube 112 extends both distally and proximally relative to the secondary tube 118.

[0096] exist Figure 5 1, the main tube 102 is attached to the neck portion 124 so that the main distal end 110 of the main tube 102 is positioned distally beyond the neck portion 124 and into the reservoir 120, and the secondary distal end 116 of the secondary tube 104 is positioned at or within the neck portion 124. The secondary proximal end 114 of the secondary tube 104 is positioned proximally relative to the neck portion 124, and the secondary distal end 116 is positioned proximally relative to the main distal end 110 of the main tube 102. Therefore, the main tube 112 extends both distally and proximally relative to the secondary tube 118.

[0097] exist Figure 6 1, the main tube 102 is attached to the neck portion 124 so that the main distal end 110 of the main tube 102 is positioned distally beyond the neck portion 124 and into the reservoir 120, and the secondary distal end 116 of the secondary tube 104 is positioned proximally relative to the neck portion 124. Therefore, the neck portion 124 is arranged or positioned between the main distal end 110 and the secondary distal end 116. The secondary proximal end 114 of the secondary tube 104 is positioned proximally relative to the neck portion 124, and the secondary distal end 116 is positioned proximally relative to the main distal end 110 of the main tube 102. Therefore, the main tube 112 extends both distally and proximally relative to the secondary tube 118.

[0098] exist Figure 3-6 In the example of FIG. 1 , the flow resistance decreases between the secondary distal end 116 of the secondary tube 104 (where the flow resistance increases relative to the primary proximal end 108 of the primary tube 102 ) and the primary distal end 110 of the primary tube 102 .

[0099] exist Figure 7 , the main tube 102 is attached to the neck portion 124 so that both the main distal end 110 of the main tube and the secondary distal end 116 of the secondary tube 104 are positioned at or within the neck portion 124. The secondary proximal end 114 of the secondary tube is also positioned at or within the neck portion 124 so that the entirety of the secondary tube is positioned or arranged at or within the neck portion 124. In other words, the length L2 can be described by the following mathematical expression: L2≤Ln.

[0100] Fig. 8A and 9 -13 shows different examples of shunt devices 100 or glaucoma drainage devices 100 for treating glaucoma according to some embodiments. The shunt device 100 has a tube 800 having a length L3 (also referred to as the "total length" or "untrimmed length" if it refers to the length before the tube is trimmed), which is defined as the length of the tube between the proximal end 812 and the distal end 814. The tube 800 has a main portion 802 with a main conduit 804 and a secondary portion 806 with a secondary conduit 808. The main portion 802 is positioned proximally relative to the secondary portion 806, and the secondary conduit 808 has a flow resistance. The shunt body 106 of the shunt device has a reservoir 120 therein, and the shunt body is integrated with the tube 800 at the secondary portion 806 so that the main conduit 804 and the secondary conduit 808 are fluidically connected to the reservoir 120.

[0101] When viewed from the proximal end 812 of the tube 800, as shown Figure 8B As shown, the secondary conduit 808 defined by the secondary portion 806 of the tube is found to have a narrower diameter, or D2, than the primary conduit 804 defined by the primary portion 802 of the tube, which has an inner diameter of D1. Thus, the secondary portion 806 defines the flow resistance of the entire tube 800.

[0102] The tube 800 has a length L3 that includes the lengths of the main portion 802 and the secondary portion 806. The secondary portion 806 has a length (L4) that is less than the length L3 and defines a distal portion of the tube 800 relative to the main portion 802. The tube also includes an intermediate or transition portion 810 positioned between the main portion 802 and the secondary portion 806 to define a transition from the main conduit 804 having a diameter D1 to the secondary conduit 808 having a diameter D2.

[0103] like Fig. 8AAs shown by the dashed arrows drawn in the figure, once implanted in the eye tissue, fluid from the environment is allowed to flow from the proximal end 812 into the main conduit 804, through the main conduit 804, then through the secondary conduit 808, and finally leave the tube 800 via the distal end 814. Since the conduit diameter of the secondary conduit 808 is smaller than that of the main conduit 804, the resistance to the fluid flowing through the tube 800 and entering the reservoir 120 is mainly determined by the smaller diameter D2 of the secondary conduit 808. Therefore, the diameter of the secondary conduit is the main determinant of the flow resistance of the fluid entering the reservoir. In some examples, the length L4 of the secondary conduit 808 may be a secondary determinant of the flow resistance of the fluid entering the reservoir 120.

[0104] The tube 800 has a portion extending proximally relative to the secondary portion 806, which is referred to as the trimmable portion 122. The trimmable portion 122 is so named because the length of the tube 800 can be adjusted by trimming or cutting the tube at the trimmable portion without affecting the flow resistance of the tube. In other words, no matter where the tube is cut or trimmed along the trimmable portion 122 to shorten the length L3 of the tube, the resulting tube (with a shorter length L3) will have the same flow resistance through it as before cutting or trimming. In some examples, the secondary conduit maintains a constant flow rate through it before and after the tube is shortened.

[0105] In addition to the reservoir 120, the shunt body 106 includes a neck portion 124, which is the portion of the shunt body 106 that contacts the tube 800. The tube 800 can be attached to the neck portion in one of a variety of configurations, as described herein with reference to FIG. Fig. 8A and 9 -13.

[0106] exist Fig. 8A 8, the tube 800 is attached to the neck portion 124 so that the distal end 814 of the tube is positioned distally beyond the neck portion and extends into the reservoir 120 to facilitate fluid flow therein, as shown by the dashed arrow extending from the distal end. The neck portion has a length (Ln) defined by the proximal end 126 and the distal end 128. A transition portion 810 defining a transition from the primary conduit 804 to the secondary conduit 808 is positioned proximally relative to the neck portion 124.

[0107] exist Fig. 9 In FIG. 8 , the tube 800 is attached to the neck portion 124 such that the distal end 814 of the tube is positioned at or within the neck portion and the transition portion 810 is positioned proximally relative to the neck portion 124 .

[0108] exist Fig.10In the embodiment, the tube 800 is attached to the neck portion 124 so that the distal end 814 of the tube and the transition portion 810 are both positioned at or within the neck portion 124, so that the entirety of the secondary portion 806 is disposed at or within the neck portion 124. In other words, the length L4 can be described by the following mathematical expression: L4≤Ln (including L4=Ln according to the example shown).

[0109] exist Figure 11-13 In the example shown, the flow diversion device 100 includes two transition sections 810A, 810B and two main sections 802A, 802B, which define two main conduits 804A, 804B located on two opposite ends of the secondary section 806. In these figures, the tube 800 includes a proximal main section 802A located proximally relative to the secondary section 806 and partially defining a proximal main conduit 804A, and a distal main section 802B located distally relative to the secondary section 806 and partially defining a distal main conduit 804B. The first transition section 810A is located between the proximal main section 802A and the secondary section 806, and the second transition section 810B is located between the distal main section 802B and the secondary section 806. The second transition section 810B is located distally relative to the first transition section 810A, and the positions of the transition sections 810A, 810B vary in the various configurations disclosed herein.

[0110] exist Fig.11 , the tube 800 is attached to the neck portion 124 such that the distal end 814 of the tube is positioned at or within the neck portion 124 and both transition portions 810A, 810B are positioned proximally relative to the neck portion 124. Thus, the distal main conduit 804B is partially positioned within the neck portion 124.

[0111] exist Fig.12 In the embodiment, the tube 800 is attached to the neck portion 124 so that the distal end 814 of the tube extends distally relative to the neck portion 124 and enters the reservoir 120. The transition portion 810B is positioned at or within the neck portion 124, and another transition portion 810B is positioned proximally relative to the neck portion 124. Thus, the secondary conduit 808 and the distal primary conduit 804B are partially arranged within the neck portion 124.

[0112] exist Fig.13 , the tube 800 is attached to the neck portion 124 such that the distal end 814 of the tube extends distally relative to the neck portion 124 and into the reservoir 120. Both transition portions 810A, 810B are positioned proximally relative to the neck portion 124. Thus, the neck portion 124 is positioned between the distal end 814 of the tube 800 and the second transition portion 810B such that the distal main conduit 804B extends through the entire length Ln of the neck portion 124.

[0113] exist Figure 11-13 In the example of FIG. 8 , the flow resistance decreases between the second transition portion 810B of the tube 800 (where the flow resistance increases relative to the proximal end 812 of the tube 800 ) and the distal end 814 of the tube 800 .

[0114] Fig.14A and Fig. 14B Two examples of transition portions 810 disclosed herein are shown. It should be noted that the transition portion can be defined as the portion of the tube 800 where the primary conduit 804 transitions to the secondary conduit 808, or vice versa, where the secondary conduit 808 transitions to the primary conduit 804 (e.g., Figure 11-13 In the latter, the construction of the transition portion 810 is understood to be the same as Fig.14A and 14B Same, but flipped vertically (or rotated 180 degrees).

[0115] exist Fig.14A In the embodiment, the transition portion 810 has a corner or edge 1400 so that the fluid, once inside the wider diameter primary conduit 804, bypasses the edge 1400 to flow into the narrower diameter secondary conduit 808. Fig. 14B In the embodiment of the present invention, the transition portion 810 has a funnel-shaped portion 1402 without corners or edges, and the funnel-shaped portion gradually reduces the diameter of the pipe. This transitions from the wider diameter of the primary pipe 804 to the narrower diameter of the secondary pipe 808 within a predetermined distance (T), which provides a smooth transition from one pipe to another (e.g., as opposed to a sharp transition). Although not shown, the transition portion can be more curved, or a more complex shape or configuration than shown, such as a stepped configuration with multiple independent transition portions positioned adjacent to each other.

[0116] Further disclosed herein is a first type of method of draining a biological fluid from a human eye via a tube(s) extending from a shunt body 106 of a glaucoma shunt device 100. The shunt device 100 may have multiple tubes (main tube 102 and secondary tube 104) or a single tube (tube 800), wherein (1) a proximal end (e.g., 108 or 812) is disposed within the human eye for receiving the biological fluid; and (2) a distal end (e.g., 110, 116, or 814) engages with the shunt body 106 to connect the proximal fluid to a reservoir 120 disposed within the shunt body 106. Once disposed in a suitable position, the biological fluid is (conduit) directed through the tube(s) at a first flow resistance at the proximal end of the tube(s), directed through the tube(s) at a second flow resistance between the proximal and distal ends of the tube(s), and directed from the distal end of the tube(s) into the reservoir 120.

[0117] In addition, a second type of method for reducing fluid pressure in the human eye to reduce the risk of hypotony is disclosed herein. In such methods, the fluid in the eye is directed to the proximal end (e.g., 108 or 812) of (one or more) tubes (e.g., main tube 102 and secondary tube 104 or single tube 800) so that (one or more) tubes have a first flow resistance at or near the proximal end (e.g., 108 or 812). The fluid is then directed to a portion of (one or more) tubes having a second flow resistance greater than the first flow resistance at or near the proximal end. The fluid is then directed from the distal end (e.g., 110, 116, or 814) of (one or more) tubes to the reservoir 120, thereby causing reduced fluid pressure in the eye.

[0118] With respect to either of the two types of methods described above, the proximal end (e.g., 108 or 812) of the tube(s) (e.g., a combination of the main tube 102 and the secondary tube 104 or a single tube 800) may be trimmed to reduce the length of the tube(s) while maintaining the second flow resistance. In some examples, the length may refer to the entire length of the single tube 800 or the total length / combined length of the coupled tubes 102 and 104 operating as a single tube. In some examples, the first flow resistance and the second flow resistance define a combined tube flow resistance, wherein the proximal end of the tube(s) may be trimmed to reduce the length of the tube(s) (e.g., the entire length or the total length / combined length) while maintaining the combined tube flow resistance. As defined herein, the combined tube flow resistance may be expressed as the sum of the first flow resistance and the second flow resistance.

[0119] In some examples of these methods, the distal end (e.g., 110, 116, or 814) of the tube(s) (e.g., a combination of the primary tube 102 and the secondary tube 104 or the single tube 800) may be arranged or otherwise positioned to extend into the reservoir 120. In some examples, the method may include, immediately after directing the fluid into a portion of the tube(s) having the second flow resistance, subsequently directing the fluid into another portion of the tube(s) having the third flow resistance.

[0120] Further disclosed herein is a third type of method, which is a method of reducing fluid pressure within a human eye to reduce the risk of hypotony, which refers to a condition of undesirable low intraocular pressure in the AC of the eye caused by a flow rate of fluid from the AC of the eye being greater than the rate at which fluid is produced in the AC, which may result in blurred vision, AC collapse, or other damage to the eye. The fluid within the eye is directed through a proximal end (e.g., 108 or 812) of (one or more) tubes (e.g., a combination of a main tube 102 and a secondary tube 104 or a single tube 800) and into a reservoir 120 disposed at a different location relative to the proximal end of the (one or more) tubes.

[0121] Between the distal end (e.g., 110, 116, or 814) and the proximal end of the tube(s) arranged adjacent to the reservoir 120, the flow resistance of the tube(s) increases to limit the flow through the tube(s) to a level sufficient to reduce the risk of hypotony. The increase in flow resistance may occur between the proximal and distal ends of the tube(s). In some examples, the proximal end of the tube(s) may be trimmed to reduce the length (i.e., the entire length or total length / combined length) of the tube(s) while maintaining the flow resistance through the tube. In some examples, the distal end of the tube(s) may be arranged to extend into the reservoir 120. In some examples, the flow resistance may decrease between the increased flow resistance and the distal end of the tube(s), where the increased flow resistance is the portion where the flow resistance of the tube(s) increases.

[0122] In addition, a method of forming a drainage device 100 that can be at least partially implanted in eye tissue is also disclosed. In some configurations, the method includes: forming a shunt body 106 having a reservoir 120 defined therein, the reservoir being configured to receive and accumulate biological fluid; preparing a main tube 102 having a main proximal end 108, a main distal end 110, and a main conduit 112 extending therebetween, and a secondary tube 104 having a secondary proximal end 114, a secondary distal end 116, and a secondary conduit 118 extending therebetween and having a flow resistance; inserting the secondary tube 104 through the main conduit 112 at least partially via the main distal end 110; and integrating the shunt body 106 with the main tube 102 near the main distal end 110, so that the main conduit 112, the secondary conduit 118 are fluidically coupled to the reservoir 120, and the main proximal end 108 of the main tube 102 can be delivered into the eye to facilitate drainage of biological fluid into the main conduit 112.

[0123] The method may include: permanently attaching a secondary tube to a primary tube; arranging an adhesive 134 between an outer surface of the secondary tube and an inner surface of the primary tube before inserting the secondary tube at least partially through the primary tube via the primary distal end; positioning the secondary distal end to extend distally beyond the primary distal end and into a reservoir; permanently attaching the primary tube to a diverter body at or near the primary distal end; positioning the primary proximal end to extend proximally beyond the secondary proximal end by a predetermined length so that the total length of the primary tube can be shortened by cutting the primary tube along a section extending proximally beyond the secondary tube without affecting the flow resistance of the secondary tube; maintaining a constant flow rate through the secondary tube before and after shortening of the primary tube through the secondary tube; and / or forming the secondary tube so that the secondary tube has a smaller diameter than the primary tube, and the diameter of the secondary tube is the primary determinant of the flow resistance of the fluid entering the reservoir, wherein the length of the secondary tube may be a secondary determinant of the flow resistance of the fluid entering the reservoir.

[0124] In some constructions, the method includes: forming a shunt body 106 having a reservoir 120 defined therein, the reservoir being configured to receive and accumulate biological fluid; preparing a tube 800 having a main portion 802 with a main conduit 804 and a secondary portion 806 with a secondary conduit 808, the main conduit 804 having a main diameter greater than a secondary diameter of the secondary conduit 808, the main portion 802 being positioned proximally relative to the secondary portion 806, and the secondary conduit 808 having a flow resistance; and integrating the shunt body 106 with the tube 800 at the secondary portion 806 so that the main conduit 804 and the secondary conduit 808 are fluidically connected to the reservoir 120, and the main portion 802 of the tube 800 can be delivered into the eye to facilitate drainage of the biological fluid into the main conduit 804.

[0125] The method may also include: extending the secondary portion of the tube at least partially distally into the storage portion; forming the tube so that the main portion extends proximally a predetermined length relative to the secondary portion, and the total length of the main portion can be shortened by cutting the main portion of the tube along a section extending proximally beyond the secondary portion without affecting the flow resistance of the secondary conduit; maintaining a constant flow rate through the secondary conduit through the secondary portion before and after shortening the main portion of the tube; and / or forming the tube so that the diameter of the secondary conduit is smaller than the diameter of the main conduit, the diameter of the secondary conduit being the primary determinant of the flow resistance of the fluid entering the storage portion, wherein the length of the secondary conduit may be a secondary determinant of the flow resistance of the fluid entering the storage portion.

[0126] The presence of a trimmable portion along the length of the tube allows the tube to be trimmed without affecting the flow resistance therein. Thus, the trimmable portion beneficially facilitates adjustability of shunt placement in a given patient's anatomy, thereby allowing the physician or surgeon using the shunt device to freely trim the tube to adjust the tube length to suit safe placement, whether the tube is placed in the patient's anterior chamber or the reservoir of the shunt device is placed on the surface of the sclera and beneath the conjunctiva.

[0127] In addition, the diverter body, which is physically and functionally coupled to the tube(s), advantageously provides a means for storing and controllably releasing fluid directed into the tube(s) in the form of a reservoir defined by the diverter body. The neck portion of the diverter body also advantageously provides structural support for the tube(s) attached to the diverter body without negatively affecting the flow resistance of the tube(s).

[0128] The material selection of the shunt device including the shunt body may include biocompatible materials, including microporous materials, such as expanded polytetrafluoroethylene (ePTFE) discussed below. (One or more) tubes can be made of materials including biocompatible materials, which are flexible and suitable for constructing elongated members. Some such suitable materials may include, but are not limited to, for example, fluorosilicone (fluorosilicone rubber), polytetrafluoroethylene, perfluorovinyl ether (PAVE), polypropylene, thermoplastic polyurethane, silicone (silicone resin), styrene block copolymers, polyether block amides or polyolefin elastomers, etc., and any suitable combination thereof. In some examples, suitable materials may also include metals. In some cases, the shunt material including the shunt body may include, for example, fluoropolymers, such as polytetrafluoroethylene (PTFE) polymers or ePTFE polymers, or any suitable combination thereof. In some cases, the material may, for example, include, but are not limited to, polyesters such as Dacron, silicones, polyurethanes, carboxymethyl cellulose fabrics or other biocompatible polymers, or any suitable combination thereof. Various modifications and additions may be made to the embodiments disclosed herein without departing from the scope of the present disclosure. For example, although the embodiments described above relate to particular features, the scope of the present disclosure also includes embodiments with different combinations of features and embodiments that do not include all of the described features. Therefore, the scope of the present disclosure is intended to cover all such substitutions, modifications and variations that fall within the scope of the claims, as well as all equivalents.

[0129] The above discussion is presented for the purpose of illustration and description. The foregoing is not intended to limit the present disclosure to one or more forms disclosed herein. For example, in the above summary of the invention, various features of the present disclosure are combined together in one or more aspects, embodiments and / or configurations for the purpose of simplifying the present disclosure. The features of the various aspects, embodiments and / or configurations of the present disclosure can be combined in other aspects, embodiments and / or configurations other than those described above. The disclosed method should not be interpreted as reflecting the intention that the claims require more features than those explicitly stated in each claim. Rather, as reflected in the attached claims, aspects of the present invention are less than all the features of a single aforementioned disclosed aspect, embodiment and / or configuration. Therefore, the following claims are incorporated herein into the specific embodiments, and each claim itself may serve as a separate preferred embodiment of the present disclosure.

[0130] In addition, although the description includes descriptions of one or more aspects, embodiments and / or configurations and some variations and modifications, other variations, combinations and modifications are also within the scope of the present disclosure, for example, as may be within the skill and knowledge of those skilled in the art after understanding the present disclosure. It is intended to obtain rights to the extent permitted including alternative aspects, embodiments and / or configurations, including structures, functions, scopes or steps that are alternative, interchangeable and / or equivalent to the claimed structures, functions, scopes or steps, whether or not such alternative, interchangeable and / or equivalent structures, functions, scopes or steps are disclosed herein, and it is not intended to publicly dedicate any patentable subject matter.

Claims

1. A glaucoma shunt device for draining biological fluid from an eye, a glaucoma shunt include: a main tube having a main proximal end, a main distal end, and a main conduit extending therebetween; a secondary tube having a secondary proximal end, a secondary distal end and a secondary conduit extending therebetween, the secondary tube being at least partially inserted through the primary conduit via the primary distal end, the secondary tube defining a flow resistance of the primary conduit and the secondary tube; as well as A diverter body having a reservoir therein and being integral with the primary conduit near the primary distal end such that the primary conduit and the secondary conduit are fluidly coupled to the reservoir.

2. The glaucoma shunt device according to claim 1, It is characterized in that The secondary pipe is permanently attached to the primary pipe.

3. The glaucoma shunt device according to claim 2, It is characterized in that The permanent attachment is facilitated by an adhesive disposed between an outer surface of the secondary pipe and an inner surface of the primary pipe.

4. The glaucoma shunt device according to claim 2, It is characterized in that The permanent attachment is facilitated by a friction fit between an outer surface of the secondary pipe and an inner surface of the primary pipe.

5. A glaucoma shunt device as claimed in any one of the preceding claims, It is characterized in that The secondary distal end extends distally beyond the primary distal end and into the reservoir.

6. The glaucoma shunt device according to any one of claims 1 to 4, It is characterized in that The diverter body includes a neck portion where the main tube is attached to the diverter body.

7. The glaucoma shunt device according to claim 6, It is characterized in that Both the primary distal end and the secondary distal end are positioned at the neck portion of the shunt body.

8. The glaucoma shunt device according to claim 6, It is characterized in that The primary distal end is positioned at the neck portion of the shunt body, and the secondary distal end is positioned proximally relative to the neck portion.

9. The glaucoma shunt device according to claim 6, It is characterized in that The primary distal end extends distally beyond the neck portion of the shunt body and into the reservoir, and the secondary distal end is positioned at the neck portion.

10. The glaucoma shunt device according to claim 6, It is characterized in that The primary distal end extends distally beyond the neck portion of the shunt body and into the reservoir, and the secondary distal end is positioned proximally relative to the neck portion.

11. The glaucoma shunt device of claim 6, It is characterized in that The sub-tube is completely disposed at or within the neck portion.

12. A glaucoma shunt device as claimed in any one of the preceding claims, It is characterized in that The main tube is permanently attached to the shunt body at or near the main distal end.

13. A glaucoma shunt device as claimed in any one of the preceding claims, It is characterized in that The main proximal end extends proximally beyond the secondary proximal end by a predetermined length to define a trimmable portion of the main tube, wherein the total length of the main tube defines a first untrimmed state of the combined main tube and secondary tube, and further defines a second state in which the combined main tube and secondary tube are trimmed to a shorter length of the trimmable portion, the first state and the second state both having the same flow resistance.

14. The glaucoma shunt device of claim 13, It is characterized in that The secondary conduit maintains a constant flow rate therethrough before and after the primary conduit is shortened.

15. A glaucoma shunt device as claimed in any one of the preceding claims, It is characterized in that The secondary conduit has a smaller diameter than the primary conduit, such that the diameter of the secondary conduit is the primary determinant of fluid flow resistance into the reservoir.

16. A glaucoma shunt device as claimed in any one of the preceding claims, It is characterized in that The length of the secondary conduit is a secondary determinant of the flow resistance of the fluid entering the reservoir.

17. A glaucoma shunt device for draining biological fluid from an eye, a glaucoma shunt include: a tube comprising a main portion having a main conduit and a secondary portion having a secondary conduit, the main conduit having a major diameter greater than a secondary diameter of the secondary conduit, the main portion being proximally positioned relative to the secondary portion, and the secondary conduit having a flow resistance; as well as A diverter body having a reservoir therein and being integral with the tube at the secondary portion such that the primary and secondary conduits are fluidly coupled to the reservoir.

18. The glaucoma shunt device of claim 17, It is characterized in that A section of the secondary portion extends distally into the reservoir.

19. The glaucoma shunt device of claim 18, It is characterized in that The diverter body includes a neck portion where the tube is attached to the diverter body.

20. The glaucoma shunt device of claim 19, It is characterized in that The distal end of the tube is positioned at the neck portion of the diverter body.

21. The glaucoma shunt device of claim 19, It is characterized in that The secondary portion of the tube is arranged completely at or within the neck portion.

22. The glaucoma shunt device of claim 18, It is characterized in that The tube further comprises: a proximal main portion positioned proximally relative to the secondary portion and partially defining the main conduit; a distal main portion located distally relative to the secondary portion and partially defining the main conduit; a first transition portion positioned between the proximal main portion and the secondary portion; and A second transition portion is positioned between the distal main portion and the secondary portion.

23. The glaucoma shunt device of claim 22, It is characterized in that The distal end of the tube is positioned at the neck portion of the diverter body, and both the first transition portion and the second transition portion are positioned proximally relative to the neck portion.

24. The glaucoma shunt device of claim 22, It is characterized in that The distal end of the tube extends distally beyond the neck portion of the shunt body and into the reservoir, the second transition portion is positioned at the neck portion, and the first transition portion is positioned proximally relative to the neck portion.

25. The glaucoma shunt device of claim 22, It is characterized in that The distal end of the tube extends distally beyond the neck portion of the shunt body and into the reservoir, and both the first transition portion and the second transition portion are positioned proximally relative to the neck portion.

26. The glaucoma shunt device according to any one of claims 17 to 25, It is characterized in that The main portion extends proximally relative to the secondary portion by a predetermined length so that the overall length of the tube can be shortened by cutting the main portion of the tube along a section extending proximally beyond the secondary portion without affecting the flow resistance of the secondary conduit.

27. The glaucoma shunt device of claim 26, It is characterized in that The secondary conduit maintains a constant flow rate therethrough before and after the main portion of the tube is shortened.

28. The glaucoma shunt device according to any one of claims 17 to 27, It is characterized in that The secondary conduit has a smaller diameter than the primary conduit, so that the diameter of the secondary conduit is the main determinant of the flow resistance of the fluid entering the reservoir.

29. The glaucoma shunt device according to any one of claims 17 to 28, It is characterized in that The length of the secondary conduit is a secondary determinant of the flow resistance of the fluid entering the reservoir.